Celmatix is a preclinical-stage biotech company focused on ovarian health. The company aims to develop treatments for conditions caused by poor ovarian health.

Celmatix

Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix’s proprietary multi-omic ovarian health platform, the world’s largest of its kind, is the foundation of the company’s novel pipeline of first-in-class therapies. For more information visit www.celmatix.com.

Long Island Angel Network

Topspin Partners

Brainchild Holdings

Richmond Global Ventures

Evotec

Special Situations Life Sciences Innovation Fund

Despite often debilitating symptoms, such conditions are still being treated with hormonal interventions introduced more than 50 years ago. The problem doesn’t stop there. Because the ovary plays a critical role in overall endocrine function, women experience serious health problems when ovarian function fails.

Have you tuned into the latest episode of Boss Ovary? https://lnkd.in/d87q2uUN 

Don't miss this episode with our CEO + Founder Piraye Beim and Aparna (Amy) Divaraniya, PhD, CEO + Founder of Oova!

Learn more about: 
✅ Impact of outdated models: How traditional healthcare models and lack of tailored data, negatively affect women's health outcomes.

✅ Empowerment through data: The benefits of having actionable, personalized health data for women to better advocate for their own health.

✅ Innovations in healthcare: How innovations like Oova's home-based monitoring are transforming healthcare practices to be more inclusive and responsive.

Our CEO Dr. Piraye Beim recently spoke to Flow Space about Rapamycin and how researchers at Columbia University Fertility Center are looking into whether the drug can be used to slow ovarian aging. 

"There’s no data on what the consequence will be of taking a completely healthy individual and putting them on Rapamycin, suppressing their immune system chronically,” explains Beim. 

Check out the full article here:

Are you heading to the Women's Health Innovation Summit in September? Our CEO + Founder, Dr. Piraye Beim,  will be speaking on the panel "Ovarian Health: Unlocking The Future of Holistic Hormone Health" with Ivana Muncie-Vasic, CEO & Founder, Vitra Labs.

This discussion highlights the latest developments and research-to-date around ovarian function. Looking at the hormones that dominate the endocrine system, this panel assesses the broader impact that an understanding of ovarian function would have on extending fertility, delaying menopause, and significantly reducing symptoms such as sweating, heart disease and dementia experienced by women throughout their lifetime.

See you there!

A study led by researchers at  Weill Cornell Medicine show changes in the brain during menopause using PET imaging technology: https://lnkd.in/d2PBRMz3

✔ The study, led by researchers at Weill Cornell Medicine, demonstrates the use of PET imaging with an ER-binding tracer, 18F-fluoroestradiol (FES), as a novel method for tracking estrogen activity in the brain, revealing its potential to predict menopause-related cognitive and mood symptoms.

✔ PET scans reveal a significant increase in brain estrogen receptor (ER) density during menopause, with postmenopausal women showing higher ER density than premenopausal women, indicating the brain's compensatory response to declining estrogen levels.

✔ Findings suggest that elevated ER density persists up to a decade after menopause, highlighting a potentially extended window for effective estrogen therapy, which the researchers plan to further investigate for its long-term effects on brain health and symptom relief.

How much do you know about AMH? Anti-Mullerian hormone (AMH) may not be the most widely discussed or well-known hormone in reproductive health, but it is certainly important to understand for a variety of reasons.   

Learn more here and drop your comments below! We'll be doing an AMA "ask me anything" with our Founder & CEO Dr. Piraye Beim soon!  https://lnkd.in/dfd38w3m

msh id	COM:CELMATIX
symbol	-
name	Celmatix
homepage url	https://www.celmatix.com
country	US
sector	Healthcare & Health Services
industry	Biotechnology
market	PRIVATE
employee count	24
crunchbase url	-
linkedin url	https://www.linkedin.com/company/celmatix
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:CELMATIX

Celmatix

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-